---
title: Newsroom | excipients
description: excipients |
---

[![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/)

- [Newsroom](https://news.lifesciencenewswire.com/newsroom)
- [Back to the main site](https://lifesciencenewswire.com/)

![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1")

# Newsroom

#### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow")

#### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg)

![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg)

### Choose a Category

- [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture)
- [AI (3)](https://news.lifesciencenewswire.com/newsroom/tag/ai)
- [Analytical Chemistry (43)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry)
- [Biomanufacturing (37)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing)
- [biopharma (24)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma)
- [Bioprocessing (17)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing)
- [Biotechnology (256)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology)
- [Cell Culture (10)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture)
- [Clinical Diagnostics (38)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics)
- [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research)
- [Clinical Research & Trials (118)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials)
- [Computing & Technology (63)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it)
- [Conferences & Events (1)](https://news.lifesciencenewswire.com/newsroom/tag/conferences-events)
- [Corporate, Finance & Investor (290)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor)
- [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19)
- [Diagnostics & Hospital Laboratory (38)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory)
- [Digital Pathology (2)](https://news.lifesciencenewswire.com/newsroom/tag/digital-pathology)
- [Drug Discovery & Development (156)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development)
- [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment)
- [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients)
- [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage)
- [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry)
- [General Laboratory (58)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory)
- [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science)
- [Healthcare (138)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare)
- [Hospital Management (7)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management)
- [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science)
- [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing)
- [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science)
- [Medical Devices & Technology (28)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology)
- [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control)
- [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging)
- [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech)
- [Omics & Genetics (90)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics)
- [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology)
- [Pharma (119)](https://news.lifesciencenewswire.com/newsroom/tag/pharma)
- [Pharmacy (5)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy)
- [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research)
- [Veterinary (6)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary)
- [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water)

See all

### Subscribe to Email Updates

<https://news.lifesciencenewswire.com/newsroom/promocell-gmbh-receives-excipact-certification-as-manufacturer-of-pharmaceutical-excipients-to-good-manufacturing-practice-gmp-standards>

 Categories: [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Cell Culture](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture), [excipients](https://news.lifesciencenewswire.com/newsroom/tag/excipients)

#### [PromoCell GmbH receives EXCiPACT™ certification as manufacturer of pharmaceutical excipients to Good Manufacturing Practice (GMP) standards](https://news.lifesciencenewswire.com/newsroom/promocell-gmbh-receives-excipact-certification-as-manufacturer-of-pharmaceutical-excipients-to-good-manufacturing-practice-gmp-standards)

 January 26, 2021

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/promocell-gmbh-receives-excipact-certification-as-manufacturer-of-pharmaceutical-excipients-to-good-manufacturing-practice-gmp-standards)

 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/promocell-gmbh-receives-excipact-certification-as-manufacturer-of-pharmaceutical-excipients-to-good-manufacturing-practice-gmp-standards#comments-listing)

 by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jan 26, 2021, 2:00:00 PM

- [Tweet](https://twitter.com/share)

[All posts](https://news.lifesciencenewswire.com/newsroom/all)

##### Browse more news

## Recent releases

<https://news.lifesciencenewswire.com/newsroom/alyssum-therapeutics-presents-phase-1-results-for-first-in-class-cmtr2-inhibitor-at-1965-at-eortc-nci-aacr>

#### [Alyssum Therapeutics Presents Phase 1 Results for First-in-Class CMTR2 Inhibitor AT-1965 at EORTC-NC...](https://news.lifesciencenewswire.com/newsroom/alyssum-therapeutics-presents-phase-1-results-for-first-in-class-cmtr2-inhibitor-at-1965-at-eortc-nci-aacr)

 November 19, 2026

Alyssum Therapeutics Inc., a clinical stage biopharmaceutical company developing a pipeline of first in class therapeutics through a patented technolo...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/alyssum-therapeutics-presents-phase-1-results-for-first-in-class-cmtr2-inhibitor-at-1965-at-eortc-nci-aacr)

<https://news.lifesciencenewswire.com/newsroom/sciensus-nurses-to-present-data-on-scalp-cooling-access-virtual-peer-support-and-post-incident-clinician-care-at-ukons-2026>

#### [Sciensus Nurses to Present Data on Scalp Cooling Access, Virtual Peer Support and Post-Incident Clin...](https://news.lifesciencenewswire.com/newsroom/sciensus-nurses-to-present-data-on-scalp-cooling-access-virtual-peer-support-and-post-incident-clinician-care-at-ukons-2026)

 November 11, 2026

Sciensus, a leading European life sciences organisation focused on accelerating patients' access to life-saving medicines, will present three posters ...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/sciensus-nurses-to-present-data-on-scalp-cooling-access-virtual-peer-support-and-post-incident-clinician-care-at-ukons-2026)

<https://news.lifesciencenewswire.com/newsroom/biognosys-launches-industrialized-discovery-to-deliver-scalable-ai-ready-proteomics-with-exceptional-cost-efficiency>

#### [Biognosys Launches Industrialized Discovery to Deliver Scalable, AI-ready Proteomics with Exceptiona...](https://news.lifesciencenewswire.com/newsroom/biognosys-launches-industrialized-discovery-to-deliver-scalable-ai-ready-proteomics-with-exceptional-cost-efficiency)

 November 10, 2026

AI-ready data by design: Standardized, quality-controlled and reproducible quantitative proteomics data, built for integration into large-scale and AI...

##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/biognosys-launches-industrialized-discovery-to-deliver-scalable-ai-ready-proteomics-with-exceptional-cost-efficiency)

![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse")

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225 

#### Useful information

- [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/)
- [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions)
- [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)